Company Listing
GammaDelta Therapeutics

GammaDelta is a new company developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. Based on the pioneering research of Professor Adrian Hayday at King’s College London and the Francis Crick Institute, the company plans to exploit unique properties of tissue resident γδ T cells for effective immunotherapy.

BACK
Location
London, UK
CEO
Paolo Paoletti
Abingworth Partner
Tim Haines
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

GammaDelta is a new company developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. Based on the pioneering research of Professor Adrian Hayday at King’s College London and the Francis Crick Institute, the company plans to exploit unique properties of tissue resident γδ T cells for effective immunotherapy.

Location
London, UK
CEO
Paolo Paoletti
Abingworth Partner
Tim Haines
Website Address
BACK
 
Copyright Abingworth 2017